Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease
The Long Run with Luke Timmerman
00:00
Joining 23andMe and building research programs
Emily recounts joining 23andMe in 2010, building neuroscience and Parkinson's efforts, and scaling the company.
Play episode from 21:51
Transcript
